Pfizer Inc. (PFE)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.54 (-2.08%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Pfizer Inc. (PFE)
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Key Insights

Critical company metrics and information

  • Share Price

    $25.29

  • Market Cap

    $143.32 Billion

  • Total Outstanding Shares

    5.67 Billion Shares

  • Total Employees

    88,000

  • Dividend

    $0.42 Per Share Quarterly

  • IPO Date

    June 22, 1951

  • SIC Description

    Pharmaceutical Preparations

  • Homepage

    https://www.pfizer.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

September 30, 2023 to September 29, 2024
MetricValue
Exchange Gains/Losses$-38.00 Million
Net Cash Flow, Continuing$-2.04 Billion
Net Cash Flow From Investing Activities, Continuing$-6.72 Billion
Net Cash Flow$-2.08 Billion
Net Cash Flow From Investing Activities$-6.72 Billion
Net Cash Flow From Financing Activities, Continuing$-6.58 Billion
Net Cash Flow From Financing Activities$-6.58 Billion
Net Cash Flow From Operating Activities, Continuing$11.26 Billion
Net Cash Flow From Operating Activities$11.26 Billion

Income Statement

September 30, 2023 to September 29, 2024
MetricValue
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Revenues$59.38 Billion
Diluted Average Shares$17.09 Billion
Diluted Earnings Per Share$0.75
Basic Earnings Per Share$0.76
Interest Expense, Operating$3.04 Billion
Operating Income/Loss$3.90 Billion
Income Tax Expense/Benefit, Deferred$-3.56 Billion
Income Tax Expense/Benefit$-402.00 Million
Preferred Stock Dividends And Other Adjustments$0.00
Operating Expenses$35.97 Billion
Net Income/Loss Attributable To Noncontrolling Interest$32.00 Million
Other Operating Expenses$20.94 Billion
Benefits Costs and Expenses$55.47 Billion
Basic Average Shares$16.99 Billion
Cost Of Revenue$19.50 Billion
Net Income/Loss Available To Common Stockholders, Basic$4.25 Billion
Income/Loss From Continuing Operations Before Tax$3.90 Billion
Gross Profit$39.87 Billion
Net Income/Loss Attributable To Parent$4.25 Billion
Selling, General, and Administrative Expenses$15.03 Billion
Costs And Expenses$55.47 Billion
Income/Loss From Discontinued Operations Net Of Tax$-22.00 Million
Income/Loss From Continuing Operations After Tax$4.30 Billion
Net Income/Loss$4.28 Billion

Balance Sheet

September 30, 2023 to September 29, 2024
MetricValue
Current Liabilities$43.21 Billion
Inventory$11.72 Billion
Equity Attributable To Parent$92.29 Billion
Other Non-current Assets$97.73 Billion
Other Current Assets$31.50 Billion
Assets$219.48 Billion
Current Assets$43.22 Billion
Accounts Payable$5.31 Billion
Intangible Assets$59.99 Billion
Other Current Liabilities$34.51 Billion
Equity$92.56 Billion
Wages$3.38 Billion
Liabilities$126.92 Billion
Noncurrent Assets$176.25 Billion
Fixed Assets$18.54 Billion
Noncurrent Liabilities$83.71 Billion
Equity Attributable To Noncontrolling Interest$272.00 Million
Liabilities And Equity$219.48 Billion

Historical Dividends

Current dividend: $0.42 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Oct 9, 2024Dec 2, 2024Nov 8, 2024$0.42Quarterly
Jun 26, 2024Sep 3, 2024Jul 26, 2024$0.42Quarterly
Apr 24, 2024Jun 14, 2024May 10, 2024$0.42Quarterly
Dec 14, 2023Mar 1, 2024Jan 26, 2024$0.42Quarterly
Oct 4, 2023Dec 4, 2023Nov 10, 2023$0.41Quarterly
Jun 22, 2023Sep 5, 2023Jul 28, 2023$0.41Quarterly
Apr 26, 2023Jun 9, 2023May 12, 2023$0.41Quarterly
Dec 9, 2022Mar 3, 2023Jan 27, 2023$0.41Quarterly
Sep 22, 2022Dec 5, 2022Nov 4, 2022$0.4Quarterly
Jun 23, 2022Sep 6, 2022Jul 29, 2022$0.4Quarterly
Apr 28, 2022Jun 10, 2022May 13, 2022$0.4Quarterly
Dec 10, 2021Mar 4, 2022Jan 28, 2022$0.4Quarterly
Sep 23, 2021Dec 6, 2021Nov 5, 2021$0.39Quarterly
Jun 24, 2021Sep 7, 2021Jul 30, 2021$0.39Quarterly
Apr 22, 2021Jun 4, 2021May 7, 2021$0.39Quarterly
Dec 11, 2020Mar 5, 2021Jan 29, 2021$0.39Quarterly
Sep 24, 2020Dec 1, 2020Nov 6, 2020$0.38Quarterly
Jun 25, 2020Sep 1, 2020Jul 31, 2020$0.38Quarterly
Apr 23, 2020Jun 5, 2020May 8, 2020$0.38Quarterly
Dec 16, 2019Mar 6, 2020Jan 31, 2020$0.38Quarterly
Sep 24, 2019Dec 2, 2019Nov 8, 2019$0.36Quarterly
Jun 27, 2019Sep 3, 2019Aug 2, 2019$0.36Quarterly
Apr 25, 2019Jun 7, 2019May 10, 2019$0.36Quarterly
Dec 14, 2018Mar 1, 2019Feb 1, 2019$0.36Quarterly
Sep 27, 2018Dec 3, 2018Nov 9, 2018$0.34Quarterly
Jun 28, 2018Sep 4, 2018Aug 3, 2018$0.34Quarterly
Apr 26, 2018Jun 1, 2018May 11, 2018$0.34Quarterly
Dec 18, 2017Mar 1, 2018Feb 2, 2018$0.34Quarterly
Sep 27, 2017Dec 1, 2017Nov 10, 2017$0.32Quarterly
Jun 22, 2017Sep 1, 2017Aug 4, 2017$0.32Quarterly
Apr 27, 2017Jun 1, 2017May 12, 2017$0.32Quarterly
Dec 12, 2016Mar 1, 2017Feb 3, 2017$0.32Quarterly
Sep 22, 2016Dec 1, 2016Nov 11, 2016$0.3Quarterly
Jun 23, 2016Sep 1, 2016Aug 5, 2016$0.3Quarterly
Apr 28, 2016Jun 1, 2016May 13, 2016$0.3Quarterly
Dec 14, 2015Mar 2, 2016Feb 5, 2016$0.3Quarterly
Sep 25, 2015Dec 1, 2015Nov 6, 2015$0.28Quarterly
Jun 25, 2015Sep 2, 2015Aug 7, 2015$0.28Quarterly
Apr 23, 2015Jun 2, 2015May 8, 2015$0.28Quarterly
Dec 15, 2014Mar 3, 2015Feb 6, 2015$0.28Quarterly
Oct 23, 2014Dec 2, 2014Nov 7, 2014$0.26Quarterly
Jun 26, 2014Sep 3, 2014Aug 1, 2014$0.26Quarterly
Apr 24, 2014Jun 3, 2014May 9, 2014$0.26Quarterly
Dec 16, 2013Mar 4, 2014Feb 7, 2014$0.26Quarterly
Oct 24, 2013Dec 3, 2013Nov 8, 2013$0.24Quarterly
Jun 27, 2013Sep 4, 2013Aug 2, 2013$0.24Quarterly
Apr 25, 2013Jun 4, 2013May 10, 2013$0.24Quarterly
Dec 17, 2012Mar 5, 2013Feb 1, 2013$0.24Quarterly
Oct 25, 2012Dec 4, 2012Nov 9, 2012$0.22Quarterly

Related Companies

View additional S&P 500 companies similar to Pfizer Inc. (PFE)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2024 Financhle. All Rights Reserved.